Quibim
AI medical imaging biomarkers
- 101-200 employees
- Healthcare
- B2B
- Artificial Intelligence
- Big data
- Deep Tech
- SaaS
- MedTech
- Mestalla, València, Spain
Jump to section
Company mission
To transform healthcare and improve human lives through AI-guided precision solutions.
Our take
Quibim develops quantitative biomarkers, companion diagnostics and other imaging tools for systems biology applications, from immuno-oncology to neurology. Specialising in advanced whole-body medical imaging, the company’s innovative AI-guided image analysis unlocks imaging data that enables doctors to make the best value-based care decisions for their patients.
The company’s algorithms find abnormalities and biomarkers in X-rays, CT scans, and PET scans to detect disease early. The company leads real-world evidence (RWE) projects with over 10 million de-identified research imaging registries from 50,000+ oncology patients.
Its also reached a significant milestone with its QP-Prostate software, earning FDA 150(k) clearance, UKCA certification, and a CE mark, further solidifying its position in the market. The company has also been selected to trial its cancer detection AI across seven NHS hospitals, marking a huge step toward real-world clinical adoption. Couples with a successful Series A funding round, Quibim is ready to expand its presence in the US while continuing to build on its success in Europe.
Freddie
Company Specialist at Welcome to the Jungle
Funding (last 2 of 8 rounds)
Jan 2025
$50m
SERIES A
Nov 2021
$5.9m
SEED
Total funding: $68.2m
This company has top investors
Leadership
Dr. Ángel Alberich-Bayarri
(Co-Founder & CEO)Previously spent nearly 7 years at Quirónsalud as a Research Engineer, R&D Scientific Coordinator and Biomedical Engineering Coordinator.
Alberto joined Quibim in 2021 as a Chief Legal Officer, moving into the role of Chief Corporate Officer in 2022 and COO in 2023. Prior to Quibim, they spent nearly 11 years at Garrigues as a Senior Associate.
Nathan Clark
(CCO)Prior to joining Quibim in 2025, Nathan spent 3 years at Riverain Technologies as a VP of Sales and as the CCO. They also spent over 7 years at Philips as a Senior Key Account Manager and as the National Leader of Account Executives for Precision Diagnosis Solutions.
Itta MacNevin
(CBO)Prior to joining Quibim in 2026, Itta spent nearly 11 years at Evotec in various roles, including Senior VP of Business Development and Head of Business Development in North America.
Jorge Navarro Clérigues
(Chief People Officer)Jorge joined Quibim in 2019 as a VP of People & Culture, moving into the role of Chief People Officer in 2023. Previously they spent nearly 8 years at Técnicas Reunidas as a HR Coordinator for the Home Office.